{"id":"W4415900084","doi":"10.1016/s2352-3026(25)00256-x","title":"Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-8): a phase 3, open-label, randomised controlled trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"GlaxoSmithKline","keywords":"Dexamethasone; Multiple myeloma; Refractory (planetary science); Randomized controlled trial; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001147021,0.0006845467,0.004232742,0.0004411192,0.0002996112,0.0001198849,0.0003572539,0.0003001675,0.00006867271],"category_scores_gemma":[0.004622124,0.0003519372,0.00008800878,0.0006168304,0.0006647369,0.0002552596,0.0003377064,0.0006803943,0.000005703253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001540671,"about_ca_system_score_gemma":0.0005074964,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006360518,"about_ca_topic_score_gemma":0.001325224,"domain_scores_codex":[0.9950137,0.001161521,0.001211929,0.0009887227,0.0005799817,0.001044106],"domain_scores_gemma":[0.9914764,0.006064899,0.000711453,0.001089574,0.0003034233,0.0003542606],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7096312,0.002913233,0.2781787,0.0001106267,0.002144096,0.001609898,0.000210529,7.759107e-7,0.00007186587,0.00007082801,0.0002050338,0.004853203],"study_design_scores_gemma":[0.8807054,0.009898067,0.1065459,0.0002994395,0.001068864,0.0002443864,0.0002136226,0.0002707946,0.0002258335,0.00003720499,0.0001465105,0.0003439747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9814653,0.0006274901,0.0000564785,0.001615078,0.0002255245,0.01523153,0.00006332678,0.00009788091,0.0006173983],"genre_scores_gemma":[0.9937383,0.0001787413,0.003055812,0.000555857,0.0000428725,0.001815087,0.0001569747,0.00007108098,0.0003852549],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1716328,"threshold_uncertainty_score":0.9998932,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04748470928783249,"score_gpt":0.3549491914005954,"score_spread":0.3074644821127629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}